Tibialis anterior tendon ruptures are rare but debilitating injuries. A high index of suspicion is warranted in patients presenting with atraumatic anterior ankle pain, especially in conjunction with diabetes or inflammatory disease. The authors present a case report of bilateral sequential rupture of tibialis anterior tendons, a discussion of management, and a review of the literature.
Introduction: Osteoid osteoma (OO) is a benign osteoblastic skeletal lesion commonly affecting the diaphysis of long bones. Intra-articular lesions, which present with atypical symptoms, are uncommon and elbow joint involvement is only rarely reported. Conservative treatment is ineffective and surgical excision or ablation is the therapeutic goal in symptomatic patients. Minimally invasive surgery is gaining popularity as a less morbid alternative in joints as opposed to open surgical excision. Herein, we report the first arthroscopic excision of an intra-articular OO involving the trochlear notch of ulna.
Case Report: A 30-year-old man presented with chronic pain and stiffness of his dominant right elbow limiting his routine activities despite treatment with analgesics. Right elbow joint showed features of moderate effusion and X-ray was normal. Computed tomography revealed an OO in the trochlear notch of ulna breaching the cortex. He underwent arthroscopic en bloc excision of the lesion followed by decompression of the surrounding sclerotic bone and radiofrequency ablation of the base. At 6th month follow-up, the patient was asymptomatic with full range of motion at elbow.
Conclusion: Periarticular OO is a debilitating illness with atypical clinical and radiological features with no response to medical treatment. Although curative, open surgical excision often adds to the morbidity in the postoperative period. Growing experience in elbow arthroscopy has made minimally invasive surgery a safe low morbid alternative procedure. However, a precise knowledge of the instrumentation and anatomy is essential to avoid incomplete excision and recurrence with arthroscopic approach.
Keywords: Osteoid osteoma, elbow, arthroscopy, stiffness, inflammatory arthritis, non-steroidal anti-inflammatory drugs.
Introduction:Rotator cuff tears are one of the common cause of shoulder pain and disability. Transosseus cuff repair is still considered as the gold standard against which other techniques are compared. We studied the functional outcome of 50 patients with rotator cuff tear treated by our novel reusable arthroscopic transosseous repair system (ArthroCuff ). Materials and methods: We performed a prospective study involving 50 patients with full thickness rotator cuff tears during the period from January 2017 to December 2107. Repair was done with the ArthroCuff system. The patients were followed up periodically at 6 months and 1 year; 2 years functional outcome was assessed for pain, Oxford Shoulder score and active range of motion. Results: At the end of 1 year and 2 years, all our patients had significant improvement in their Oxford Score, range of motion and pain relief. Two patients were trailing behind the mean at 6 months but they improved at 12 months. The results are comparable with other available transosseous systems and arthroscopic double row repair techniques. Conclusion: Arthroscopic transosseous repair though a reliable and cost-effective alternate to suture anchors, is not widely available in India. So, in association with the National Hub for Healthcare Device Development, we developed ArthroCuff. For cost-conscious countries a reusable system to provide a robust rotator cuff repair is the need of the hour and we believe surgeons and patients can benefit from the multiple advantages that exist with this system.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.